Max Chat
Ono Pharmaceutical Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
9.37 | 112.41 | -91.67% | 15.95 | -41.27% |
| P/S |
|
2.38 | 75.54 | -96.84% |
|
|
| P/BV |
|
1.5 | 70.29 | -97.86% |
|
|
| P/FCF |
|
15.03 | 28.67 | -47.58% |
|
|
| Ev/Ebitda |
|
5.72 | 29.32 | -80.48% |
|
|
| Ev/S |
|
2.07 | 73.15 | -97.17% |
|
|
| Ev/FCF |
|
11.59 | 27.26 | -57.47% |
|
|
| E/P |
|
0.0948 | 0.4676 | -79.72% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
36.2 | -49.16 | -173.64% | 36.64 | -1.2% |
| ROE |
|
16.68 | 1.13 | 1372.2% |
|
|
| ROA |
|
14.25 | 0.6587 | 2063.39% |
|
|
| ROIC |
|
19.96 | 9.07 | 119.97% |
|
|
| ROS |
|
25.46 | -83.08 | -130.65% |
|
|
| ROCE |
|
20.52 | -1.97 | -1143.11% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0487 | 4.43 | -98.9% | 0.0596 | -18.32% |
| Nеt Debt/Ebitda |
|
-0.8643 | 15.16 | -105.7% |
|
|
| Debt/Ratio |
|
0.0097 | 0.1487 | -93.48% |
|
|
| Debt/Equity |
|
0.1441 | 1.11 | -86.98% |
|
|
| Debt/Net Income |
|
0.0692 | -2.47 | -102.81% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
6.86 | 2.86 | 139.56% | 4.25 | +61.3% |
| Number of years of dividend growth |
|
3 | 1.43 | 109.43% | ||
| DSI |
|
0.9286 | 0.7453 | 24.59% |
|
|
| Average dividend growth |
|
9.65 | -140.78 | -106.86% |
|
|
| Average percentage for 5 years |
|
4.25 | 38.17 | -88.86% |
|
|
| Average percentage for payments |
|
33.34 | 34.62 | -3.69% |
|
|
| Difference from average difference in sector |
|
4 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
8/10
|
71.9 | 1533.14 | -95.31% | ||
| Growth impulse Ebitda in 5 years |
|
92.04 | 3726.29 | -97.53% | ||
| Growth impulse Net Income in 5 years |
|
114.37 | 2596.48 | -95.6% | ||
| Growth impulse FCF in 5 years |
|
73.72 | 2353.76 | -96.87% | ||
| Growth impulse EPS in 5 years |
|
125.07 | 3216.29 | -96.11% |
IP Score
8.46/10
